Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 hours agoThe vaccine is based on protein technology, differentiating it from Pfizer's and Moderna's messenger...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 10 hours agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 9 hours agoThe vaccine, dubbed...older adults it can be serious or even deadly. Moderna will rival Pfizer and...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 7 days agoModerna's vaccine was approved for the prevention of RSV-associated lower respiratory tract disease...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 5 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 3 days agoChatterjee and Wharton were speaking during a meeting of the FDA's Vaccines and Related Biological...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 day agoThis approval represents a significant development...vaccine to enter the US market following the...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
Moderna's RSV Vaccine Approved by FDA
Medscape· 5 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations ...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...